Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Myriad Genetics Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 196
- +8 vs. Q3 2022
- Shares held
- 80.6M
- −844.0K (−1.0%) vs. Q3 2022
- Total value
- $1.17B
- −$384.9M (−24.8%) vs. Q3 2022
- New holders
- 28
- 73 more added
- Sold out
- 20
- 66 more reduced
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $507.8M |
| Q1 2026 | 204 | $519.2M |
| Q4 2025 | 221 | $567.1M |
| Q3 2025 | 221 | $639.8M |
| Q2 2025 | 221 | $480.5M |
| Q1 2025 | 228 | $832.9M |
| Q4 2024 | 221 | $1.27B |
| Q3 2024 | 246 | $2.48B |
| Q2 2024 | 223 | $2.25B |
| Q1 2024 | 186 | $2.00B |
| Q4 2023 | 194 | $1.72B |
| Q3 2023 | 186 | $1.33B |
| Q2 2023 | 188 | $1.88B |
| Q1 2023 | 190 | $1.91B |
| Q4 2022 | 196 | $1.17B |
| Q3 2022 | 191 | $1.55B |
| Q2 2022 | 199 | $1.46B |
| Q1 2022 | 205 | $1.99B |
| Q4 2021 | 197 | $2.16B |
| Q3 2021 | 213 | $2.56B |
| Q2 2021 | 201 | $2.31B |
| Q1 2021 | 197 | $2.25B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Myriad Genetics Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −30,238−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −28,188−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −26,760−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −26,245−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −26,093−100.0% | Sold out |
| Zebra Capital Management LLC | 0 | $0 | 0.00% | −13,672−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −11,400−100.0% | Sold out |
| Globeflex Capital L P | 0 | $0 | 0.00% | −10,545−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −3,337−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −2,405−100.0% | Sold out |
| Jackson, Grant Investment Advisers, Inc. | 0 | $0 | 0.00% | −1,032−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −504−100.0% | Sold out |
| Plante Moran Financial Advisors, LLC | 0 | $0 | 0.00% | −244−100.0% | Sold out |
| Investors Asset Management of Georgia Inc | 0 | $0 | 0.00% | −202−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| De Burlo Group Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |
| Surevest, LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |